Share:

Fund Peregrine Pharmaceutical to Test Bavi for Herpes

Public Comments (924)
  • Jan 23rd, 2011
    Someone from Fort Irwin, CA writes:
    Quotation mark icon
    It's time to get rid of this horrible disease. With the help of our congress, we shall provide more funding towards herpes simplex virus. This virus has changed many peoples lives including new born babies passing away due to the virus attacking their immune system. It's unfair to those babies to suffer such fate because a cure hasn't been pursued. Lack of funding is showing our government being irresponsible. They're meaning universities and companies researching a herpes cure. Peregrine Pharmaceuticals has gone on record saying they're antiviral Bavituximab has shown extremely positive results on herpes simplex virus. It's time to focus on this disease... No more delays
    REPORT COMMENTS

    Do you want to report these comments to the moderator for removal? They should be offensive, threatening, a duplicate submission, or spam.

       
    No, Cancel
  • Jan 23rd, 2011
    Someone from Woodbridge, VA signed.
  • Jan 23rd, 2011
    Someone from Miami, FL writes:
    Quotation mark icon
    Please help.
    REPORT COMMENTS

    Do you want to report these comments to the moderator for removal? They should be offensive, threatening, a duplicate submission, or spam.

       
    No, Cancel
  • Jan 23rd, 2011
    Someone from Pilot Mountain, NC writes:
    Quotation mark icon
    As a US taxpayer and citizen I realize it is time for the US government to take concern for ALL of it's citizens. Charity begins at home. Peregrine is testing Bavi for almost everything and much of this is being funded by the US Department of Defense. Add a little money to this, test for herpes and potentially cure/treat millions while adding to the tax base of the US by creating badly needed jobs!
    REPORT COMMENTS

    Do you want to report these comments to the moderator for removal? They should be offensive, threatening, a duplicate submission, or spam.

       
    No, Cancel